cover
Contact Name
Mohammad Rizki Fadhil Pratama
Contact Email
mohammadrizkifadhilpratama@gmail.com
Phone
-
Journal Mail Official
lp2m@umpalangkaraya.ac.id
Editorial Address
-
Location
Kota palangkaraya,
Kalimantan tengah
INDONESIA
Jurnal Surya Medika
ISSN : 24607266     EISSN : 26552051     DOI : -
Core Subject : Health, Science,
The publication of Jurnal Surya Medika certainly participates in disseminating the results of research and review of science and technology development conducted by lecturers and researchers especially from UM Palangkaraya and other universities. This edition contains 17 articles consisting of Pharmacy, Medical Laboratory Technology, and another Health Science topics.
Arjuna Subject : -
Articles 822 Documents
Studi Penggunaan Obat Pada Pasien Sindrom Ovarium Polikistik (Pcos) Di Rsud Haji Provinsi Jawa Timur Shella Anggraini; Asri Wido Mukti; Novamei Indriani; Rosy Nurlita Hapsari
Jurnal Surya Medika (JSM) Vol. 12 No. 2 (2026): Jurnal Surya Medika (JSM)
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/jsm.v12i2.13547

Abstract

Polycystic Ovary Syndrome (PCOS) is the most common endocrine-metabolic disorder among women of reproductive age, yet comprehensive data on its drug utilization pattern in Indonesian regional hospitals remain limited, particularly in East Java. This study aimed to describe the drug utilization pattern in PCOS patients at RSUD Haji East Java Province during 2020-2025. A descriptive retrospective design was applied using total sampling of 57 outpatient medical records meeting the inclusion criteria, analyzed descriptively using Microsoft Excel. Results showed that monotherapy was the predominant treatment pattern (70.2%), with hormonal therapy being the most frequently used drug class (78.9%). The most commonly prescribed drugs were norethisterone 5 mg (43.9%) and Cycloprogynova (40.4%), while metformin was used in 14.0% of patients and clomiphene citrate (Diphten) as an ovulation-inducing agent in 12.3% of patients. Doses and frequencies were mostly consistent with standard literature, with two frequency variations found for Diane 35 and Microgynon, reflecting the prescribing physician's clinical judgment. Documented adverse effects were found in only one patient (1.8%), consisting of dizziness potentially associated with metformin. All patients (100%) showed clinical improvement in the form of menstrual return within 2 to 6 days after therapy. It is concluded that PCOS drug utilization at RSUD Haji is dominated by hormonal therapy with favorable clinical response, although the completeness of medical record documentation should be improved to support comprehensive therapy monitoring.
Selected Herbal Galactagogues In Indonesian Postpartum Care: A Narrative Review Integrating Product Standardization, Maternal Factors, And Infant Outcomes: Selected Herbal Galactagogues In Indonesian Postpartum Care: A Narrative Review Integrating Product Standardization, Maternal Factors, And Infant Outcomes Nurul Qamariah; Putu Andina Pramitasari; Putu Aditya Adi Purbawa
Jurnal Surya Medika (JSM) Vol. 12 No. 1 (2026): Jurnal Surya Medika (JSM)
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/jsm.v12i1.13921

Abstract

Herbal galactagogues are widely used during the postpartum period, but evidence should be interpreted at the level of a defined preparation rather than a plant name alone. This narrative review integrates natural-product science, obstetrics, and pediatrics to examine Moringa oleifera (kelor), Phyllanthus androgynus (syn. Sauropus androgynus; katuk), and Coleus amboinicus (syn. Plectranthus amboinicus; torbangun). A targeted literature search prioritized recent systematic reviews, clinical trials, cohort studies, and phytochemical studies, while retaining selected landmark evidence. Clinical findings suggest preparation-specific signals of benefit, but differences in botanical identity, processing, dose, postpartum timing, lactation phenotype, and outcome measurement limit generalization. Natural-product evaluation requires authenticated material, reproducible preparation, chemical fingerprinting, and contaminant control. Maternal assessment should identify obstetric and metabolic contributors to delayed lactogenesis, while pediatric assessment should verify milk transfer, hydration, growth, jaundice risk, and possible exposure-related adverse events. We propose a preparation-specific mother-infant dyad framework in which herbal products are considered only as monitored adjuncts after modifiable causes of low milk production or transfer are addressed. This framework provides a more reproducible and clinically interpretable basis for future Indonesian galactagogue research